Skip to content
Bored Studies
RecruitingPhase 2

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

BioMarin Pharmaceutical · NCT06382155

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 3–11 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 2
Target enrollment
100
US sites recruiting
31
Study start
October 21, 2024
Record last updated
May 22, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH)(hGH; only in the United States), in children with idiopathic short stature (ISS).

Being studied: Vosoritide Injection; Human Growth Hormone; Placebo

Conditions: Idiopathic Short Stature

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Key Inclusion Criteria

  • Height assessment corresponding to a height Z-score of ≤ -2.25 SDs in reference to the general population of the same age and sex, as calculated using the Centers for Disease Control and Prevention (CDC) growth charts
  • If participant is ≥ 5 years at Screening,must be Tanner Stage I to be eligible for enrollment and randomization3. Historic stimulation test result with serum or plasma GH level greater than 10 μg/L or serum IGF-1 in the normal range for age (≥ -1.00 SDs and ≤+2.00 SDs).

Key Exclusions

  • Known chromosomal imbalance or genetic variant causing short stature syndrome, including but not limited to Laron syndrome, Prader-Willi syndrome, Russell-Silver Syndrome, Turner syndrome, disproportionate skeletal dysplasias, abnormal SHOX gene analysis, or Rasopathy (including Noonan syndrome), ACAN deficiency.
  • Previous treatment with a growth promoting agent

Recruiting US locations

  • Consano Clinical Research, LLC

    California City, CA 78231

    Site contact: Daniel Katselnik · 210-545-4900 · katselnik.MD@ConsanoSA.com

  • Rady Children's Hospital - San Diego

    California City, CA 92123

    Site contact: Mary (Marybeth) Patterson · 858-966-4032 · mpatterson2@rchsd.org

  • Children's Hospital of Orange County Main Campus - Orange

    California City, CA 92868

    Site contact: Amrit Bhangoo · +17145098634 · abhangoo@choc.org

  • Children's Hospital Los Angeles

    Los Angeles, CA 90027

    Site contact: Anna Ryabets-Lienhard · 323-361-6478 · aryabets@chla.usc.edu

  • Children's Hospital Oakland Research Institute

    Oakland, CA 94609

    Site contact: Dr Hannah Chesser · hannah.chesser@ucsf.edu

  • Center Of Excellence in Diabetes and Endocrinology

    Sacramento, CA 95821

    Site contact: Dr Gnanagurudasan Prakasam · 916-570-2756 · Gnanagurudasan.Prakasam@sutterhealth.org

  • Lundquist Institute for Biomedical Innovation (LA BioMed)

    Torrance, CA 90502

    Site contact: Dr Lynda Polgreen · 3102221961 · lpolgreen@lundquist.org

  • The Children's National Research Institute

    Washington D.C., DC 20012

    Site contact: Dr Andrew Dauber · adauber@childrensnational.org

  • Nemours Children's Specialty Care Jacksonville

    Jacksonville, FL 32207

    Site contact: Dr Larry Fox · larry.fox@nemours.org

  • Nicklaus Children's Hospital

    Miami, FL 33155

    Site contact: Dr Adriana Carrillo Iregui · adriana.carrillo@nicklaushealth.org

  • Optimal Research Sites

    Orange City, FL 32763

    Site contact: Dr Jaqueline Freyre-Cubano · 386-218-5911 · jfreyre@optimalresearchsites.net

  • Nemours Children's Health System - Corporate Headquarters

    Pensacola, FL 32514

    Site contact: Dr Jean-Claude Desmangles · 850-505-4793 · jean-claude.desmangles@nemours.ort

  • Centricity Research

    Columbus, GA 31904

    Site contact: Steven Leichter Principal Investigator · 833-3235646 · sleichter@centricityresearch.com

  • Rocky Mountain Clinical Research - Idaho Falls

    Idaho Falls, ID 83404

    Site contact: Dr Joshua Smith · 208-522-6005 · jms-research@idahomed.com

  • University of Iowa Stead Family Children's Hospital

    Iowa City, IA 52242

    Site contact: Dr Michael Tansey · (319) 356-4443 · michael-tansey@uiowa.edu

  • Kentucky Children's Hospital

    Lexington, KY 40536

    Site contact: Dr Yuri Zarate · 859-257-1000 · yuri.zarate@uky.edu

  • University of Louisville School of Medicine

    Louisville, KY 40202

    Site contact: Dr Catalina Cabrera Salcedo · catalina.salcedo@louisville.edu

  • Velocity Clinical Research - MedPharmics - Lafayette

    Lafayette, LA 70508

    Site contact: Dr Jibran Atwi · (337) 519-4742 · jiatwi@velocityclinical.com

  • University of Michigan

    Ann Arbor, MI 48109

    Site contact: Dr Inas H. Thomas · 734-674-5175 · inash@med.umich.edu

  • University of Minnesota Masonic Children's Hospital

    Minneapolis, MN 55454

    Site contact: Dr Bradley Miller · 612-626-2916 · mille685@umn.edu

  • UBMD Pediatrics

    Buffalo, NY 14203

    Site contact: Dr Teresa Quattrin · 716-323-0170 · tquattrin@upa.chob.edu

  • Atlantic Health Children's Specialty Center at Morristown

    New York, NY 07960

    Site contact: Dr Lawrence Silverman · 973-971-4340 · lawrence.silverman@atlantichealth.org

  • The Clinical and Translational Science Institute

    New York, NY 10016

    Site contact: Dr Emily Breidbart · (212) 263-5290 · emily.breidbart@nyulangone.org

  • Icahn School of Medicine at Mount Sinai

    New York, NY 10029

    Site contact: Robert Rapaport · (212) 241-8523 · robert.rapaport@mountsinai.org

  • Children's Hospital at Montefiore

    The Bronx, NY 10467

    Site contact: Dr Laurie Cohen · (718)920-4664 · lacohen@montefiore.org

  • University of North Carolina Children's Specialty Clinic

    Chapel Hill, NC 27514

    Site contact: Nina Jain · 919-718-9512 · nina_jain@med.unc.edu

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, OH 45229

    Site contact: Dr Gajanthan Muthuvel · (513) 636-8444 · gajanthan.muthuvel@cchmc.org

  • Prisma Health Children's Hospital - Midlands

    Columbia, SC 29203

    Site contact: Dr Alison Lunsford · 803-434-7990 · alison.lunsford@prismahealth.org

  • University of Texas Southwestern Medical Center

    Dallas, TX 75390

    Site contact: Dr Nadia Merchant · 214-456-5959 · nadia.merchant@utsouthwestern.edu

  • Baylor College of Medicine

    Houston, TX 77030

    Site contact: Dr Lin Yuezhen · yuezhenl@bcm.edu

  • Seattle Children's Hospital

    Seattle, WA 98105

    Site contact: Dr Patricia Fechner · 206-884-8540 · patricia.fechner@seattlechildrens.org

Study contacts (from the official record)

  • Trial Specialist · +1 415.475.5852 · medinfo@bmrn.com
A Phase 2 Study of Vosoritide in Children With Idiopathic Short… (NCT06382155) | Bored Studies